Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych TopicsPsychopharmacology — rTMS, VNS and DBS

Psych · Psychopharmacology — rTMS, VNS and DBS

rTMS, VNS and deep brain stimulation

Also known as repetitive transcranial magnetic stimulation · rTMS · iTBS · theta burst stimulation · vagus nerve stimulation · VNS · deep brain stimulation depression · subcallosal cingulate DBS · SAINT · SNT · neurostimulation psychiatry

Exam-exhaustive fellowship reference on rTMS/iTBS, implanted vagus nerve stimulation, and deep brain stimulation for treatment-resistant depression — protocols, safety, landmark trials (O'Reardon, George, THREE-D, SAINT/SNT, Rush VNS, Mayberg/Holtzheimer/Dougherty DBS), evidence ladder versus ECT, and regional access. FRANZCP-primary, globally tagged.

medium18 referencesUpdated 26 July 202611 min readVerification in progress

Practise this topic

  • 10 MCQs

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Psychotic depression, catatonia, food–fluid refusal, or high-intent suicidality needing rapid reliable response — prefer ECT pathways over elective outpatient rTMS
  • Ferromagnetic intracranial metal, cochlear implant incompatibility, or uncontrolled epilepsy — stop and complete device-specific rTMS safety screen before stimulation
  • Peri-rTMS clinical seizure — abort session, ABC support, do not 'push through' remaining trains that day
  • Selling DBS as routine proven therapy for depression after failed tablets — pivotal SCC and VC/VS sham RCTs failed primary endpoints
  • Acute VNS sham RCT negative primary outcome — do not oversell implant as guaranteed rapid antidepressant
  • Capacity lost for implant decisions — use jurisdiction-specific substitute decision / mental health law; never invent section numbers
On this page
Study tools

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Psychotic depression, catatonia, food–fluid refusal, or high-intent suicidality needing rapid reliable response — prefer ECT pathways over elective outpatient rTMS
  • Ferromagnetic intracranial metal, cochlear implant incompatibility, or uncontrolled epilepsy — stop and complete device-specific rTMS safety screen before stimulation
  • Peri-rTMS clinical seizure — abort session, ABC support, do not 'push through' remaining trains that day
  • Selling DBS as routine proven therapy for depression after failed tablets — pivotal SCC and VC/VS sham RCTs failed primary endpoints
  • Acute VNS sham RCT negative primary outcome — do not oversell implant as guaranteed rapid antidepressant
  • Capacity lost for implant decisions — use jurisdiction-specific substitute decision / mental health law; never invent section numbers
The one-line fellowship answer

rTMS/iTBS is non-invasive outpatient cortical stimulation for ambulatory treatment-resistant depression — the classic left DLPFC scaffold is ~120 percent resting motor threshold, 10 Hz, ~3000 pulses per session, 5 days a week for ~4–6 weeks, and iTBS delivers the same benefit in ~3 minutes versus ~37 minutes of 10 Hz in THREE-D. Implanted left cervical VNS is a delayed-benefit adjunct for chronic multi-failure TRD whose acute sham RCT primary was negative; DBS of mood-circuit nodes remains research-tier because the pivotal sham-controlled SCC and VC/VS depression trials failed their primary endpoints. ECT is the emergency tool; this topic is the elective outpatient device ladder.[1][6][9][13][17][18]

Meet the patient — "doctor, what about that magnet treatment?"

A 42-year-old nurse has run through sertraline, venlafaxine and mirtazapine — adequate dose, adequate duration, genuine adherence, confirmed with her GP and her pharmacist. She is not psychotic, not catatonic, still eating and drinking, no recent attempt, and she goes to work in tears. She hands you a printout on rTMS with one paragraph circled in yellow.[9][12]

Her partner wants ECT "to just fix it"; she wants "the magnet, not the electricity"; the registrar mentions a chest implant "that sends signals up a nerve." Sorting those three asks — without embarrassment, and without promising what the trials do not deliver — is exactly what this topic is for.[9][12]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References18ShowHide
  1. [1]O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial Biol Psychiatry, 2007.PMID 17573044
  2. [2]George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial Arch Gen Psychiatry, 2010.PMID 20439832
  3. [3]Berlim MT, van den Eynde F, Tovar-Perdomo S, et al. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials Psychol Med, 2014.PMID 23507264
  4. [4]Lefaucheur JP, André-Obadia N, Antal A, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) Clin Neurophysiol, 2014.PMID 25034472
  5. [5]Lefaucheur JP, Aleman A, Baeken C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018) Clin Neurophysiol, 2020.PMID 31901449
  6. [6]Blumberger DM, Vila-Rodriguez F, Thorpe KE, et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial Lancet, 2018.PMID 29726344
  7. [7]Cole EJ, Stimpson KH, Bentzley BS, et al. Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression Am J Psychiatry, 2020.PMID 32252538
  8. [8]Cole EJ, Phillips AL, Bentzley BS, et al. Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial Am J Psychiatry, 2022.PMID 34711062
  9. [9]McClintock SM, Reti IM, Carpenter LL, et al. Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression J Clin Psychiatry, 2018.PMID 28541649
  10. [10]Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research Clin Neurophysiol, 2009.PMID 19833552
  11. [11]Rossi S, Antal A, Bestmann S, et al. Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines Clin Neurophysiol, 2021.PMID 33243615
  12. [12]Milev RV, Giacobbe P, Kennedy SH, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments Can J Psychiatry, 2016.PMID 27486154
  13. [13]Rush AJ, Marangell LB, Sackeim HA, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial Biol Psychiatry, 2005.PMID 16139580
  14. [14]Rush AJ, Sackeim HA, Marangell LB, et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study Biol Psychiatry, 2005.PMID 16139581
  15. [15]Aaronson ST, Sears P, Ruvuna F, et al. A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality Am J Psychiatry, 2017.PMID 28359201
  16. [16]Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression Neuron, 2005.PMID 15748841
  17. [17]Holtzheimer PE, Husain MM, Lisanby SH, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial Lancet Psychiatry, 2017.PMID 28988904
  18. [18]Dougherty DD, Rezai AR, Carpenter LL, et al. A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression Biol Psychiatry, 2015.PMID 25726497

Test yourself

Practise what you just read

  • 10 MCQs
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousRisk assessment in forensic settingsForensic psychiatry — risk assessmentNextSchool and workplace mental healthPublic and community psychiatry — school and workplace mental health